About this item:

322 Views | 401 Downloads

Author Notes:

Corresponding Author: Omer Kucuk, Winship Cancer Institute, Emory University, 1365 Clifton Road NE, Atlanta, GA 30322, USA. Email: okucuk@emory.edu

SA acknowledges the Indian Council of Medical Research (ICMR) for providing ICMR International Fellowship for Senior Biomedical Scientists 20l8-2019.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Subjects:

Research Funding:

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Oncology
  • Integrative & Complementary Medicine
  • prostate cancer
  • genistein
  • chemotherapy
  • radiotherapy
  • TERM GENISTEIN INTERVENTION
  • LOCALIZED PROSTATE-CANCER
  • FACTOR-KAPPA-B
  • METHOTREXATE TOXICITY
  • ANTIOXIDANT SUPPLEMENTATION
  • CHEMOTHERAPEUTIC-AGENTS
  • ENDOTHELIAL-CELLS
  • BREAST-CANCER
  • PROTECTS
  • CISPLATIN

Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy

Tools:

Journal Title:

Integrative Cancer Therapies

Volume:

Volume 18

Publisher:

, Pages 1534735419835310-1534735419835310

Type of Work:

Article | Final Publisher PDF

Abstract:

Soy consumption in human diet has been linked to decreased incidence of a variety of cancers, suggesting a potential role of soy products in cancer prevention and control. Furthermore, a substantial body of evidence in the literature suggests that soy supplementation may improve the efficacy and prevent the adverse effects of cancer chemotherapy and radiation therapy. Isoflavones constitute the predominant anticancer bioactive compounds in soy. Genistein, which is the most abundant and active isoflavone in soy, has a multitude of effects on cancer cells, including inhibition of NF-κB activation and DNA methylation, enhancement of histone acetylation, inhibition of cell growth and metastasis, and antiangiogenic, anti-inflammatory, and anti-oxidant effects. Isoflavones are orally bioavailable, easily metabolized, and usually considered safe. In this article, we review in vitro and in vivo evidence as well as the results of clinical and epidemiological studies on the effects of soy isoflavones, with a focus on sensitization of cancer cells to chemotherapy and radiation while at the same time protecting normal cells from the harmful effects of these treatments.

Copyright information:

© The Author(s) 2019.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/).

Creative Commons License

Export to EndNote